Free Trial
NASDAQ:APVO

Aptevo Therapeutics (APVO) Stock Price, News & Analysis

Aptevo Therapeutics logo
$3.02 -0.02 (-0.66%)
Closing price 07/3/2025 03:54 PM Eastern
Extended Trading
$3.02 +0.00 (+0.03%)
As of 07/3/2025 04:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Aptevo Therapeutics Stock (NASDAQ:APVO)

Key Stats

Today's Range
$2.93
$3.05
50-Day Range
$2.82
$12.24
52-Week Range
$2.81
$485.37
Volume
130,195 shs
Average Volume
607,584 shs
Market Capitalization
$2.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$219,040.00
Consensus Rating
Buy

Company Overview

Aptevo Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
43rd Percentile Overall Score

APVO MarketRank™: 

Aptevo Therapeutics scored higher than 43% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aptevo Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Aptevo Therapeutics has received no research coverage in the past 90 days.

  • Read more about Aptevo Therapeutics' stock forecast and price target.
  • Earnings Growth

    Earnings for Aptevo Therapeutics are expected to grow in the coming year, from ($15.84) to ($14.49) per share.

  • Price to Book Value per Share Ratio

    Aptevo Therapeutics has a P/B Ratio of 0.05. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Aptevo Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    1.50% of the float of Aptevo Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Aptevo Therapeutics has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aptevo Therapeutics has recently increased by 21.28%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Aptevo Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Aptevo Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.50% of the float of Aptevo Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Aptevo Therapeutics has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aptevo Therapeutics has recently increased by 21.28%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Aptevo Therapeutics this week, compared to 0 articles on an average week.
  • Search Interest

    16 people have searched for APVO on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Aptevo Therapeutics to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aptevo Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.01% of the stock of Aptevo Therapeutics is held by insiders.

  • Percentage Held by Institutions

    Only 8.06% of the stock of Aptevo Therapeutics is held by institutions.

  • Read more about Aptevo Therapeutics' insider trading history.
Receive APVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

APVO Stock News Headlines

APVO Aptevo Therapeutics Inc. - Seeking Alpha
APVO - Aptevo Therapeutics Inc Sustainability - Morningstar
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
See More Headlines

APVO Stock Analysis - Frequently Asked Questions

Aptevo Therapeutics' stock was trading at $86.20 at the start of the year. Since then, APVO stock has decreased by 96.5% and is now trading at $3.02.

Aptevo Therapeutics Inc. (NASDAQ:APVO) posted its quarterly earnings results on Thursday, May, 15th. The biotechnology company reported ($87.80) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($84.20) by $3.60.

Aptevo Therapeutics shares reverse split on Wednesday, March 6th 2024.The 1-44 reverse split was announced on Wednesday, March 6th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, March 6th 2024. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of APVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aptevo Therapeutics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Alibaba Group (BABA), Plug Power (PLUG) and Micron Technology (MU).

Company Calendar

Last Earnings
5/15/2025
Today
7/05/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:APVO
Employees
50
Year Founded
2016

Price Target and Rating

Average Stock Price Target
$219,040.00
High Stock Price Target
$219,040.00
Low Stock Price Target
$219,040.00
Potential Upside/Downside
+7,252,880.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$24.13 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.11 million
Price / Cash Flow
N/A
Book Value
$65.21 per share
Price / Book
0.05

Miscellaneous

Free Float
756,000
Market Cap
$2.30 million
Optionable
Not Optionable
Beta
5.58

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:APVO) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners